Nasiratu Larry

Nasiratu Larry practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Nasiratu Larry's NPI, 1689069742, was assigned on April 5, 2015. Nasiratu Larry holds New York license 294925.

Nasiratu Larry's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

Nasiratu Larry's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Nasiratu Larry is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Nasiratu Larry to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nasiratu Larry practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Nasiratu Larry's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Nasiratu Larry is licensed in New York.

CMS data shows 768 Medicare services from Nasiratu Larry across 3 procedure codes in 2024, for 245 Medicare patients. Medicare paid $72,871 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 245 Medicare patients who saw Nasiratu Larry in 2024. The largest group is 85 and over, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nasiratu Larry's median patient age at 83, with 56% women.

In 2024, Nasiratu Larry wrote 330 Medicare Part D claims for 104 patients. 86% of them were for generic drugs. CMS names the drug for 111 of them, across 6 drugs with 11 or more claims each, at $14,212 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Nasiratu Larry for performance year 2024, reported through an alternative payment model (APM). Nasiratu Larry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Nasiratu Larry from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $29.